BJ Messinger-Rapport, DR Thomas, JK Gammack, … - Journal of the American …, 2008 - Elsevier In 2007 we provided an overview of clinical advances in the nursing home based on a series
of presentations at the American Medical Directors Association. 1 This will now be a regular yearly
series. Topics covered this year are nutrition, exercise, diabetes mellitus, lipids, ... Cited by 3 - Related articles - All 2 versions
K Van Acker, D Bouhassira, D De Bacquer, S Weiss, … - Diabetes and Metabolism, 2009 - Elsevier The prevalence of DPN was 43% (95% CI 40.1–45.9), and was higher in type 2 (50.8%) than
in type 1 (25.6%) diabetic patients. The prevalence of DPN-P was 14% (95% CI 12.1–16.2)
which, again, was higher in type 2 (17.9%) than in type 1 (5.8%) patients. These ... Cited by 2 - Related articles - All 3 versions
NT Options, PT Options - annalsoflongtermcare.com Although the pathophysiology of diabetic neuropathy is unclear, most experts believe that hyperglycemia
is the cause of the nerve damage in DPN.48 Hyperglycemia causes increased levels of intracellular
glucose in nerves, leading to saturation of the normal glycolytic pathway.49 Nevertheless, ... Related articles - Cached
V Kluša, J Rumaks, Ñ Karajeva - Proceedings of the Latvian Academy of …, 2008 - Versita Diabetic neuropathy is a heterogenous peripheral nerve dis- order caused by diabetes (for review
see Wong et al., 2007; Ziegler, 2008). About 60 to 70 per cent of people with dia- betes have
some form of neuropathy. Diabetic neuropathy affects all peripheral nerves: pain fibres, ... Related articles
Y Zhang, P Huang, T Jiang, J Zhao, N Zhang - Molecular Biology Reports - Springer Abstract Accumulation of glomerular extracellular matrix (ECM) may result in
glomerulosclerosis. Several lines of evidence indicate a key role for transforming growth fac-
tor-b1 (TGF-b1) in glomerular ECM synthesis and degra- dation, such as fibronectin (FN). ... Related articles - All 2 versions
P Assistants, N Practitioners - annalsoflongtermcare.com One of the most frequent microvascular complications of type 2 diabetes is diabetic
neuropathy, which affects sensory, autonomic, and motor neurons of the peripheral nervous
system. Diabetic neuropathy is estimated to be present in half of the people living with ... Related articles - Cached
AJM Boulton - Current Diabetes Reports, 2008 - Springer Introduction: One of the biggest challenges for the practic- ing physician caring for patients with
diabetes is managing painful neuropathy. The large number of drugs that have been used in
managing neuropathy suggests that the ideal treatment is yet to be discovered [1,2]. ... Related articles - All 2 versions
D Neuropathy, CDNB Prevented - Prevalence - diabetesinmichigan.org Page 1. Ann Scott RN MSN Diabetes Educator TIPDON Visit TIPDON's Web Site
www.diabetesinmichigan.org Professional Workshops Self‐Study Modules Resource
Directory for Self‐Management Education Programs and ... Related articles - View as HTML - All 5 versions
BW Lee, SJ Kwon, HY Chae, JG Kang, CS … - Free Radical …, 2009 - informahealthcare.com The beneficial properties of α-LA in the treatment of diabetes include not only the relief of symptoms
of diabetic polyneuropathy but also the partial amelioration of insulin resistance by increasing
insulin-stimulated glucose uptake [5], [6]. Recently, the anti-obesity and ... Cited by 2 - Related articles - All 3 versions
V Opletalova, J Jampilek, J Dolezel, P Hirsova, J … - usc.es 2 Zentiva as, U kabelovny 130, 102 37 Prague 10, Czech Republic; e-mail:
josef.jampilek@zentiva.cz, tel.: +420-2-67243695, fax: +420-2-72701331 3 Department of Chemical
Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, ... Related articles - View as HTML
